TR201200215A2 - Geliştirilmiş farmasötik formülasyonlar. - Google Patents

Geliştirilmiş farmasötik formülasyonlar.

Info

Publication number
TR201200215A2
TR201200215A2 TR2012/00215A TR201200215A TR201200215A2 TR 201200215 A2 TR201200215 A2 TR 201200215A2 TR 2012/00215 A TR2012/00215 A TR 2012/00215A TR 201200215 A TR201200215 A TR 201200215A TR 201200215 A2 TR201200215 A2 TR 201200215A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical formulations
improved pharmaceutical
improved
alendronate
prevention
Prior art date
Application number
TR2012/00215A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/00215A priority Critical patent/TR201200215A2/tr
Publication of TR201200215A2 publication Critical patent/TR201200215A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılacak alendronat içeren farmasötik formülasyonlara ilişkindir.@
TR2012/00215A 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar. TR201200215A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.

Publications (1)

Publication Number Publication Date
TR201200215A2 true TR201200215A2 (tr) 2012-07-23

Family

ID=45771873

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.

Country Status (3)

Country Link
EP (1) EP2661257B1 (tr)
TR (4) TR201100153A2 (tr)
WO (1) WO2012093978A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
TR200900880A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.

Also Published As

Publication number Publication date
TR201200216A2 (tr) 2012-07-23
EP2661257B1 (en) 2017-11-15
TR201200214A2 (tr) 2012-07-23
TR201100153A2 (tr) 2012-07-23
EP2661257A1 (en) 2013-11-13
WO2012093978A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
IN2014MN00948A (tr)
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
EP3466408C0 (en) LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE OF THE POSTERIOR EYE
TW201129382A (en) Antibody formulation and therapeutic regimens
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
HUE039864T2 (hu) Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére
EA201991484A1 (ru) Лекарственные формы энзалутамида
MX2019003249A (es) Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
EA201590165A1 (ru) Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
SMT201400150B (it) Composizioni terapeutiche comprendenti rilpivirinacloridrato e tenofovir disoproxil fumarato
IN2014MN00987A (tr)
MX2012013731A (es) Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas.
EP2849738C0 (en) HIGH PENETRATION PRODRUG COMPOSITIONS AND ASSOCIATED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY CONDITIONS
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
HUE053409T2 (hu) Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
EA201201296A1 (ru) Способы лечения диабетических язв стопы
EA201270728A1 (ru) Пуриновые соединения